9
| XLS Download |
|
Total revenues, sales, operating result (EBIT) and R&D costs, by division (€ million) |
|||||||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
Biopharma- |
Consumer Health |
Performance Materials |
Life science tools division |
Group* |
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|||||||||||||||||
|
2012 |
|
|
|
|
|
||||||||||||
|
Total revenues |
6,405.2 |
475.2 |
1,675.6 |
2,616.9 |
11,172.9 |
||||||||||||
|
Sales |
5,995.8 |
472.6 |
1,674.2 |
2,598.2 |
10,740.8 |
||||||||||||
|
Operating result (EBIT)** |
547.7 |
7.6 |
609.7 |
251.7 |
963.6 |
||||||||||||
|
R&D costs |
1,187.3 |
19.4 |
137.4 |
166.1 |
1,511.3 |
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
2013 |
|
|
|
|
|
||||||||||||
|
Total revenues |
6,325.8 |
479.6 |
1,644.4 |
2,645.3 |
11,095.1 |
||||||||||||
|
Sales |
5,953.6 |
476.9 |
1,642.1 |
2,627.5 |
10,700.1 |
||||||||||||
|
Operating result (EBIT)** |
893.0 |
62.2 |
653.3 |
262.0 |
1,610.8 |
||||||||||||
|
R&D costs |
1,182.8 |
17.1 |
143.0 |
159.8 |
1,504.3 |
||||||||||||
Merck KGaA, Darmstadt, Germany, achieved strong full-year results, meeting its objectives for 2013 despite a challenging market environment. The company, which offers top-quality high-tech products in the pharmaceutical and chemical sectors, reported solid organic sales growth of 4.2% to € 10.7 billion. Thanks to the accelerated implementation of efficiency measures, EBITDA pre one-time items increased by 9.7% to a record € 3.25 billion. The EBITDA pre margin increased by nearly three percentage points from 27.6% to 30.4%.
Merck KGaA, Darmstadt, Germany, posted a considerable increase of 67.2% in the operating result (EBIT), which amounted to € 1.61 billion (2012: € 964 million). This was due on the one hand to the good performance of operating business and on the other to the sharp decline in the very high level of one-time items incurred in 2012 due to restructuring measures.
At € 1,504 million, R&D costs in 2013 remained at the 2012 level.
See Annual Report 2013, Development of total revenues and sales as well as results of operations
